Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study
|2||Active, not recruiting||
Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity
|3||Active, not recruiting||
Evaluating New Formulation of Therapeutic HSV-2 Vaccine
Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine
Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine
† Study has passed its completion date and status has not been verified in more than two years.